WITHDRAWN: The Atlas of Inflammation Resolution (AIR).

Journal

Molecular aspects of medicine
ISSN: 1872-9452
Titre abrégé: Mol Aspects Med
Pays: England
ID NLM: 7603128

Informations de publication

Date de publication:
29 08 2020
Historique:
pubmed: 3 9 2020
medline: 3 9 2020
entrez: 3 9 2020
Statut: aheadofprint

Résumé

The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.mam.2020.100894. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Identifiants

DOI: 10.1016/j.mam.2020.100893 PMID: 32873427
pubmed: 32873427
pii: S0098-2997(20)30095-9
doi: 10.1016/j.mam.2020.100893
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100893

Subventions

Organisme : Medical Research Council
ID : MR/K013068/1
Pays : United Kingdom

Auteurs

Charles N Serhan (CN)

Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.

Shailendra K Gupta (SK)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Mauro Perretti (M)

The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

Catherine Godson (C)

Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.

Eoin Brennan (E)

Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.

Yongsheng Li (Y)

Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.

Oliver Soehnlein (O)

Department of Physiology and Pharmacology (FyFA), Karolinska Institutet, 17177, Stockholm, Sweden; German Center for Cardiovascular Research (DZHK), München, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University, 80336, München, Germany.

Takao Shimizu (T)

Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, 113-0033, Tokyo, Japan; National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan.

Oliver Werz (O)

Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743, Jena, Germany.

Valerio Chiurchiù (V)

Institute of Translational Pharmacology, National Research Council, 00133, Rome, Italy; Laboratory of Resolution of Neuroinflammation, IRCCS Santa Lucia Foundation, 00143, Rome, Italy.

Angelo Azzi (A)

School of Graduate Biomedical Pharmacology and Drug Development Program at Tufts University, Boston, MA, 02111, USA.

Marc Dubourdeau (M)

Ambiotis, Canal Biotech 2 - 3 Rue des Satellites, 31400, Toulouse, France.

Suchi Smita Gupta (SS)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Patrick Schopohl (P)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Matti Hoch (M)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Dragana Gjorgevikj (D)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Faiz M Khan (FM)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

David Brauer (D)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.

Anurag Tripathi (A)

CSIR - Indian Institute of Toxicology Research, 226001, Lucknow, India.

Konstantin Cesnulevicius (K)

Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.

David Lescheid (D)

Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.

Myron Schultz (M)

Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.

Eva Särndahl (E)

IRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden.

Dirk Repsilber (D)

School of Medical Sciences, University of Örebro, SE-701 82, Örebro, Sweden.

Robert Kruse (R)

IRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden.

Angelo Sala (A)

Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, and IRIB, C.N.R, 90146, Palermo, Italy.

Jesper Z Haeggström (JZ)

Department of Medical Biochemistry and Biophysics, Karolinska Institute, SE-171 77, Stockholm, Sweden.

Bruce D Levy (BD)

Brigham and Women's Hospital, Department of Medicine, Pulmonary and Critical Care Medicine and Harvard Medical School, Boston, MA, 02115, USA.

János G Filep (JG)

Department of Pathology and Cell Biology, University of Montreal, Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, H1T 2M4, Canada.

Olaf Wolkenhauer (O)

Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany; Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa. Electronic address: olaf.wolkenhauer@uni-rostock.de.

Classifications MeSH